Page last updated: 2024-10-20

pyrazinamide and Granulocytic Leukemia, Chronic

pyrazinamide has been researched along with Granulocytic Leukemia, Chronic in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research Excerpts

ExcerptRelevanceReference
"Here, we report a case of peritoneal tuberculosis which was successfully treated with a non-rifampin based regimen in tandem with ongoing administration of a tyrosine kinase inhibitor, dasatinib, for CML."1.42Diseases at the crossroads: chronic myelogenous leukemia and tuberculosis. ( Adelakun, A; Bhatnagar, V; Chen, Q; Emadi, A; Farshidpour, M; Holtzman, N; Kendall, T; Stevenson, B, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatnagar, V1
Adelakun, A1
Kendall, T1
Holtzman, N1
Farshidpour, M1
Stevenson, B1
Chen, Q1
Emadi, A1

Other Studies

1 other study available for pyrazinamide and Granulocytic Leukemia, Chronic

ArticleYear
Diseases at the crossroads: chronic myelogenous leukemia and tuberculosis.
    Archives of Iranian medicine, 2015, Volume: 18, Issue:1

    Topics: Adult; Antitubercular Agents; Dasatinib; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Le

2015